In addition, MIP-1δ, MCP-2, TIMP-1, RANTES, IGFBP3, and TNF-α expression levels were significantly different between the preradiotherapy and postradiotherapy groups and may thus be closely associated with bone metastasis-related pain. Here, CCL15 is linked to bone metastasis.